First in human study with a prodrug of galantamine: Improved benefit-risk ratio?
| Autor: | Baakman, Anne C., 't Hart, Ellen, Kay, Denis G., Stevens, Jasper, Klaassen, Erica S., Maelicke, Alfred, Groeneveld, Geert J. |
|---|---|
| Zdroj: | In Alzheimer's & Dementia: Translational Research & Clinical Interventions January 2016 2(1):13-22 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Plný text